Alzheimer's Association campaigns for broader Leqembi coverage: report,After CMS slapped down a petition for...
Biogen
Biogen's new CEO Chris Viehbacher looks to ads, patient outreach to boost promotion of...
Eisai, Biogen's high-stakes Leqembi filing nets FDA priority review—and an AdComm hearing,After scoring an...
Opinion | No Country for Alzheimer’s Patients,Biden’s CMS refuses Medicare coverage despite evidence of...
CMS restricts coverage of amyloid-targeting Alzheimer's antibodies,CMS has denied the Alzheimer's Association's request asking...
Safety concerns hang over new Alzheimer's treatment,Two deaths linked to the drug may present...
